• Brett, S.J., Baxter, G., Cooper, H., Rowan, W., Regan, T., Tite, J., Rapson, N. (1996) Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment. International Immunology, 8, 325334.
  • Hertenstein, B., Wagner, B., Bunjes, D., Duncker, C., Raghavachar, A., Arnold, R., Heimpel, H., Schrezenmeier, H. (1995) Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood, 86, 14871492.
  • Hill, S.J., Peters, S.H., Ayliffe, M.J., Merceica, J., Bansal, A.S. (1999) Reduced IL-4 and interferon-gamma (IFN-gamma) expression by CD4 T cells in patients with chronic lymphocytic leukaemia. Clinical and Experimental Immunology, 117, 811.
  • Hulkkonen, J., Vilpo, J., Vilpo, L., Hurme, M. (1998) Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group. British Journal of Haematology, 100, 478483.DOI: 10.1046/j.1365-2141.1998.00595.x
  • Lagneaux, L., Delforge, A., Dorval, C., Bron, D., Stryckmans, P. (1993) Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood, 82, 23792385.
  • Nissen, C., Tichelli, A., Gratwohl, A., Varthmann, C., Moser, Y., Dalle Carbonare, V., Sendelove, S., Chkloskaia, E., Jansen, W., Wodnar-Filipowicz, A., Sadallah, S., Speck, B. (1999) High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia. A possible role of high endogenous interleukin (IL) -2 in their suppression. Acta Haematologica, 101, 165172.
  • Rowan, W., Tite, J., Topley, P., Brett, S.J. (1998) Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells. Immunology, 95, 427436.DOI: 10.1046/j.1365-2567.1998.00615.x
  • Rawstron, A.C., Rollinson, S.J., Richards, S., Short, M.A., English, A., Morgan, G.J., Hale, G., Hillman, P. (1999) The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment. British Journal of Haematology, 107, 148153.
  • Taylor, V.C., Sims, M., Brett, S., Field, M.C. (1997) Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochemical Journal, 322, 919925.